WHO vaccine-preventable diseases: monitoring system. 2019 global summary

Last updated 15-July-2019 (data as of 1-July-2019)
Next overall update Winter 2019
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 3'8401 Infant (under 12 months) mortality rate: 212
GDP / capita (US$): 13'0571 Child (under 5 years) mortality rate: 252

Population data in thousands3

  2018  2017  2016  2015  2014  2000  1990  1980 
Total population 267'671  264'651  261'556  258'383  255'128  211'514  181'413  147'448 
Births 4'834  4'871  4'910  4'947  4'981  4'613  4'686  4'939 
Surviving infants 4'744  4'776  4'808  4'839  4'866  4'424  4'397  4'520 
Pop. less than 5 years 24'350  24'718  24'794  24'428  24'264  21'305  22'253  21'965 
Pop. less than 15 years 71'070  71'231  71'229  70'929  70'844  64'919  66'127  60'593 
Female 15-49 years 144'017  142'833  141'649  140'568  139'215  117'276  92'161  69'821 

Number of reported cases

(Click for retrospective incidence data for Indonesia)
Diphtheria
ChartChart
  1'026  954  342  430  23  2'200  3'674 
Japanese encephalitis
ChartChart
  281  43  40  72 
Measles
ChartChart ChartChart
  5'300  9'035  6'962  15'099  12'943  3'344  92'105  28'935 
Mumps
ChartChart
 
Pertussis
ChartChart
  40  1'043  826  2'082  142  30'014  32'999 
Polio*
  35  465  182 
Rubella
ChartChart
  1'767  1'264  1'238  2'156  3'542 
Rubella (CRS)
ChartChart
  188  532  174  44 
Tetanus (neonatal)
ChartChart
  14  25  33  79  75  466  1'427  954 
Tetanus (total)**
ChartChart
  506  522  1'032  466  7'784  7'231 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Indonesia)
Vaccine year result method % card seen                                                
BCG 2016  87  EPI   35  89  93  90  90  94  87  94  61 
DTP1 2016  65  EPI   35  79  90  90  90  98  87 
DTP3 2016  61  EPI   35  76  85  84  84  95  77  88 
IPV1          66  47 
HepB_BD          54  32  82  86  55 
HepB3 2016  61  EPI   35  79  85  85  84  95  65 
Hib3 2016  61  EPI   35  79  85  85  93  44 
JapEnc          71 
MCV1          85  90  88  87  95  73  85 
MCV2          52  63  55  31  28 
MenA         
PCV1          57  16 
PCV2          53 
PCV3         
Pol3 2016  68  EPI   35  79  88  85  85  95  74  89 
Rota1         
RotaC         
RCV1          57  16 
TT2plus 2011  45  DHS   41  47  65  65  65  52  81  61 
PAB         
VAD1          87  85  60 
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid July 2020

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Indonesia)
BCG
ChartChart
  81  82  81  80  82  81  74  61 
DTP1
ChartChart
  85  86  85  85  85  84  82 
DTP3
ChartChart
  79  79  79  78  78  75  60 
HepB3
ChartChart
  79  79  79  78  78  65 
HepB_BD
ChartChart
  54  32 
Hib3
ChartChart
  79  79  79  78  30 
IPV1
  66  47 
MCV1
ChartChart
  75  75  76  75  75  76  58 
MCV2
ChartChart
  67  63  55  31  28 
PCV3
 
Pol3
ChartChart
  80  80  80  80  80  72  60 
RCV1
ChartChart
  40  15 
RotaC
 

Click to download WHO-UNICEF coverage estimates data for PAB time series.
Click to download WHO-UNICEF coverage estimates data for HPV time series.

Number of districts in the country 514  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
94 
   
/
|
|
\
Greater or equal to 90% 48
From 80 to 89% 23
From 50 to 79% 22
Less than 50% 7
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2018 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes live birth infant
DT 6-7 years; Yes 1st grade in school
DTwPHibHepB 2, 3, 4, 18 months; Yes children under 2 years
HepB_Pediatric birth; Yes live birth infant
HPV 11, 12 years; No
IPV 4 months; Yes
JE_LiveAtd 10 months; No only in Bali province
Measles 7 years; No Only in 28 provinces out of province in Java island before MR campaign
MR 9, 18 months; 7 years; No Start in 6 provinces in Java Islands, other 28 provinces will start using MR after MR campaign ends
OPV 1, 2, 3, 4 months; Yes surviving infant
Pneumo_conj 2, 3, 12 months; No Only in West Lombok, East Lombok, Central Lombok districts and Mataram City
Td 7-8, 9-10, 15-39 years; Yes CBAW (15-39 years)
VitaminA 6-11, 12-59 months; Yes

Immunizaton indicators

Indicator Expected answer 2018  2017  2016  2015  2014  2013  2012 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2015-2019  2015-2019  2015-2019  2015-2019  2015-2019  2010-2014  2010-2014 
Nº of districts with microplans that include activities to raise immunization coverage number   NA    514  179  184  58 

System performance

Total Nº districts in country number 514  514  514  514  509  497  497 
Nº districts with DTP3 coverage >=80% number 364  398  380  356  369  412  392 
% of districts with DTP3 coverage >=80% From 0 to 100% 71  77  74  69  72  83  79 
Nº districts with measles (MCV1) coverage >=95% number 199  197  191  181  207  226  269 
% of districts with MCV1 coverage >=95% From 0 to 100% 39  38  37  35  41  45  54 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% NA    88  76  64  60   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

 1  "The 2019 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  UN Inter-agency Group for Child Mortality Estimation (https://childmortality.org/data)  
 3  "United Nations, Population Division. The World Population Prospects - the 2019 revision". New York, 2019.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.